Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02514486 · ClinicalTrials.gov registry record
Assessment of Cancer Concerns at the End of Treatment (ACE)
A clinical trial, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- 332
- Enrollment target
NCT02514486: Completed study, sponsored by Abramson Cancer Center at Penn Medicine.
NCT02514486 is a clinical trial that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 332 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02514486 has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- 332 participants
- Enrollment target
Study Summary
This study will describe patient-reported symptom burden and concerns, quality of life (QOL), and health behaviors of breast cancer(BC) survivors who have completed initial treatments (e.g., surgery, chemotherapy, and/or radiotherapy), assess the feasibility of using a web-based platform to collect patient-reported outcome (PRO) data, and evaluate provider satisfaction following delivery of an electronic health record (HER)/EPIC summary of these PROs. Secondary aims will estimate differences in referral to available services between those providers exposed to the PRO summary and historical controls. BC survivors who have completed initial treatment and present within the first year following treatment for an end of treatment (EOT)/survivorship focused visit will be the focus of this study.
Interventions
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 332 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-01-19 |
What the finished NCT02514486 record still lists
NCT02514486 is an observational study that tracks outcomes without assigning an intervention. The registered 332 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT02514486 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02514486 about?
NCT02514486 is a clinical study titled "Assessment of Cancer Concerns at the End of Treatment (ACE)". This study will describe patient-reported symptom burden and concerns, quality of life (QOL), and health behaviors of breast cancer(BC) survivors who have completed initial treatments (e.g., surgery, chemotherapy, and/or radiotherapy), assess the feasibility of using a web-based platform to collect ...
What is the current status of trial NCT02514486?
This trial is currently completed. The enrollment target is 332 participants. The study started on 2014-07. Estimated completion is 2018-01-19.
What interventions are being tested in trial NCT02514486?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02514486?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174121 · 332 participants · Phase 2
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- NCT02605785 · 332 participants · NA
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- NCT04894006 · 332 participants · NA
Dementia Family Caregiver Study
- NCT05130606 · 332 participants · NA
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia